Tag : 55M

Latest News

Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy

Newsemia
The company hopes to use the money to bring its T-cell antigen coupler cell therapy technology – currently in preclinical development – into human clinical...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy